Drugs / BAY86-4367
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00975299 | Sep 2009 → Oct 2010 | — | Bayer | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BAY86-4367 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00975299 ↗ |
| Modality | Diagnostic / imaging agent | “18F Labeled PET Tracer BAY86-4367” NCT00975299 ↗ |
| Route | Intravenous | “single intravenous bolus injection of 300 MBq BAY86-4367” NCT00975299 ↗ |